Retroviral-Mediated Transfer of the Iduronate-2-Sulfatase Gene into Lymphocytes for Treatment of Mild Hunter Syndrome (Mucopolysaccharidosis Type II). University of Minnesota Medical School, Minneapolis, Minnesota
- 1 March 1996
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 7 (4) , 537-549
- https://doi.org/10.1089/hum.1996.7.4-537
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Detection of point mutations and a gross deletion in six Hunter Syndrome patientsGenomics, 1992
- Intermediate form of mucopolysaccharidosis type II (Hunter disease): A C1327 to T substitution in the iduronate sulfatase geneBiochemical and Biophysical Research Communications, 1992
- The iduronate sulfatase gene: Isolation of a 1.2-Mb YAC contig spanning the entire gene and identification of heterogeneous deletions in patients with Hunter syndromeGenomics, 1992
- Long-Term Improvement of Hypercholesterolemia After Ex Vivo Gene Therapy in LDLR-Deficient RabbitsScience, 1991
- The Hypogonadal Mouse: Reproductive Functions Restored by Gene TherapyScience, 1986
- Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantationNature, 1984
- Partial correction of murine hereditary growth disorder by germ-line incorporation of a new geneNature, 1984
- BONE MARROW TRANSPLANTATION FOR INBORN ERRORSThe Lancet, 1981
- REVERSAL OF CLINICAL FEATURES OF HURLER'S DISEASE AND BIOCHEMICAL IMPROVEMENT AFTER TREATMENT BY BONE-MARROW TRANSPLANTATIONThe Lancet, 1981
- Hurler and Hunter Syndromes: Mutual Correction of the Defect in Cultured FibroblastsScience, 1968